Willkie advised Clovis Oncology on the deal. Clovis Oncology, Inc., a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the U.S., Europe,...
You must be a Standard 1 Year member to access this content.
Willkie Farr & Gallagher represented Ariel Alternatives in the transaction. Ariel Alternatives, LLC, the private equity subsidiary of global asset manager Ariel Investments, LLC, announced its...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Dotmatics, while Willkie Farr & Gallagher LLP advised Insightful Science on the deal. Insightful Science, a leading software provider serving the global...
You must be a Standard 1 Year member to access this content.
